Implantable Neurostimulators Global Market Report 2025

Description

Implantable neurostimulators are medical devices designed to deliver electrical impulses to targeted areas of the nervous system to modify or regulate nerve activity. These devices are commonly used to treat chronic pain, neurological disorders, and other conditions involving impaired nerve function. The primary goal of an implantable neurostimulator is to either regulate abnormal nerve signals or stimulate underactive nerves.

The key types of implantable neurostimulators include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Spinal cord stimulators (SCS) are designed to send electrical impulses to the spinal cord, blocking pain signals before they reach the brain. These devices are used for a variety of conditions, including pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and more. End users of these devices include hospitals, ambulatory surgical centers (ASCs), and others.

The implantable neurostimulators market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulators market statistics, including implantable neurostimulators industry global market size, regional shares, competitors with a implantable neurostimulators market share, detailed implantable neurostimulators market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulators industry. This implantable neurostimulators market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable neurostimulators market size has grown rapidly in recent years. It will grow from $6.06 billion in 2024 to $6.76 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic pain, increasing aging population, improved reimbursement policies, government funding and support, and expanding indications.

The implantable neurostimulators market size is expected to see rapid growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing prevalence of neurological disorders, growth in minimally invasive procedures, healthcare expenditure growth, rising demand for non-opioid pain management, collaborations and partnerships. Major trends in the forecast period include technology advancements, diversification beyond chronic pain, miniaturization and AI-powered personalization, remote monitoring and digital therapeutics, product innovation.

The growing prevalence of neurological disorders is expected to drive the expansion of the implantable neurostimulators market. Neurological disorders affect the nervous system, including the brain and spinal cord, impacting functions such as movement and cognition. The rise in such disorders is largely attributed to the aging population, as longer lifespans increase susceptibility to conditions such as Alzheimer's and Parkinson's disease. Implantable neurostimulators are devices that deliver electrical impulses to manage symptoms, such as tremors and pain, associated with conditions such as epilepsy and Parkinson's. For instance, the World Federation of Neurology reported in October 2023 that over 40% of the global population currently suffers from some form of neurological condition, with this burden expected to nearly double by 2050. This increasing prevalence is fueling growth in the implantable neurostimulators market.

Key players in the implantable neurostimulators market are focusing on developing advanced technologies, such as rechargeable spinal cord stimulators, to improve patient comfort, simplify surgical procedures, and enhance pain management treatments. Rechargeable spinal cord stimulators are devices implanted to relieve chronic pain by delivering electrical signals to the spinal cord. For example, in December 2022, Abbott Laboratories, a U.S.-based healthcare product manufacturer, received FDA approval for the Eterna spinal cord stimulation (SCS) system. This device, the smallest of its kind, is designed for chronic pain relief and utilizes Abbott's proprietary BurstDR stimulation technology, which mimics natural brain patterns to achieve 23% more effective pain reduction than traditional methods. The Eterna SCS system also features Xtend energy technology, requiring as few as five charges per year, reducing the need for frequent recharging. It supports full-body MRI scans and is upgradeable for future advancements.

In September 2023, Amber Therapeutics Ltd., a medical technology company based in the UK, acquired Bioinduction Ltd. for an undisclosed sum. This acquisition will allow Bioinduction to strengthen its ability to develop innovative neuromodulation therapies, particularly aimed at treating mixed urinary incontinence (MUI). Bioinduction Ltd. specializes in creating unique implantable neuromodulation devices within the medical technology sector.

Major companies operating in the implantable neurostimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova plc, Inspire Medical Systems Inc., Nevro Corporation, Axonics Inc., Cirtec Medical Systems LLC, SPR Therapeutics Inc., BlueWind Medical Ltd., NeuroPace Inc., Bioness Inc., ReShape Lifesciences Inc., Synapse Biomedical Inc., Autonomic Technologies Inc., Comphya SA, Mainstay Medical Holdings plc, Sigenics Inc., Nalu Medical Inc., Aleva Neurotherapeutics SA, Nuvectra Corporation

North America was the largest region in the implantable neurostimulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulators market consists of sales of peripheral nerve stimulators, myostimulators, spinal cord stimulators, and brain stimulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable neurostimulators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Spinal Cord Stimulators; Deep Brain Stimulators; Sacral Nerve Stimulators; Vagus Nerve Stimulators; Other Product Types
2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
3) By End-Use: Hospitals; Ambulatory Surgical Centers (ASCs); Other End-Uses
Subsegments:
1) By Spinal Cord Stimulators: Conventional Spinal Cord Stimulators; Rechargeable Spinal Cord Stimulators; Non-Rechargeable Spinal Cord Stimulators; High-Frequency Spinal Cord Stimulators
2) By Deep Brain Stimulators: Single Lead Deep Brain Stimulators; Dual Lead Deep Brain Stimulators; Rechargeable Deep Brain Stimulators; Non-Rechargeable Deep Brain Stimulators
3) By Sacral Nerve Stimulators: Rechargeable Sacral Nerve Stimulators; Non-Rechargeable Sacral Nerve Stimulators; Implantable Pulse Generators for Sacral Nerve Stimulation
4) By Vagus Nerve Stimulators: Rechargeable Vagus Nerve Stimulators; Non-Rechargeable Vagus Nerve Stimulators; Vagus Nerve Stimulation Systems for Epilepsy Treatment
5) By Other Product Types: Transcranial Magnetic Stimulation (TMS) Devices; Peripheral Nerve Stimulators; Cochlear Implants
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; LivaNova plc; Inspire Medical Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33496

1. Executive Summary

2. Implantable Neurostimulators Market Characteristics

3. Implantable Neurostimulators Market Trends And Strategies

4. Implantable Neurostimulators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Neurostimulators Growth Analysis And Strategic Analysis Framework

5.1. Global Implantable Neurostimulators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Implantable Neurostimulators Market Growth Rate Analysis
5.4. Global Implantable Neurostimulators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Implantable Neurostimulators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Implantable Neurostimulators Total Addressable Market (TAM)

6. Implantable Neurostimulators Market Segmentation

6.1. Global Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Other Product Types
6.2. Global Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Parkinson's Disease
Urinary And Fecal Incontinence
Epilepsy
Gastroparesis
Other Applications
6.3. Global Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers (ASCs)
Other End-Uses
6.4. Global Implantable Neurostimulators Market, Sub-Segmentation Of Spinal Cord Stimulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Spinal Cord Stimulators
Rechargeable Spinal Cord Stimulators
Non-Rechargeable Spinal Cord Stimulators
High-Frequency Spinal Cord Stimulators
6.5. Global Implantable Neurostimulators Market, Sub-Segmentation Of Deep Brain Stimulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Lead Deep Brain Stimulators
Dual Lead Deep Brain Stimulators
Rechargeable Deep Brain Stimulators
Non-Rechargeable Deep Brain Stimulators
6.6. Global Implantable Neurostimulators Market, Sub-Segmentation Of Sacral Nerve Stimulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rechargeable Sacral Nerve Stimulators
Non-Rechargeable Sacral Nerve Stimulators
Implantable Pulse Generators for Sacral Nerve Stimulation
6.7. Global Implantable Neurostimulators Market, Sub-Segmentation Of Vagus Nerve Stimulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rechargeable Vagus Nerve Stimulators
Non-Rechargeable Vagus Nerve Stimulators
Vagus Nerve Stimulation Systems for Epilepsy Treatment
6.8. Global Implantable Neurostimulators Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transcranial Magnetic Stimulation (TMS) Devices
Peripheral Nerve Stimulators
Cochlear Implants

7. Implantable Neurostimulators Market Regional And Country Analysis

7.1. Global Implantable Neurostimulators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Implantable Neurostimulators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Neurostimulators Market

8.1. Asia-Pacific Implantable Neurostimulators Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Neurostimulators Market

9.1. China Implantable Neurostimulators Market Overview
9.2. China Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Neurostimulators Market

10.1. India Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Neurostimulators Market

11.1. Japan Implantable Neurostimulators Market Overview
11.2. Japan Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Neurostimulators Market

12.1. Australia Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Neurostimulators Market

13.1. Indonesia Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Neurostimulators Market

14.1. South Korea Implantable Neurostimulators Market Overview
14.2. South Korea Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Neurostimulators Market

15.1. Western Europe Implantable Neurostimulators Market Overview
15.2. Western Europe Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Neurostimulators Market

16.1. UK Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Neurostimulators Market

17.1. Germany Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Neurostimulators Market

18.1. France Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Neurostimulators Market

19.1. Italy Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Neurostimulators Market

20.1. Spain Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Neurostimulators Market

21.1. Eastern Europe Implantable Neurostimulators Market Overview
21.2. Eastern Europe Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Neurostimulators Market

22.1. Russia Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Neurostimulators Market

23.1. North America Implantable Neurostimulators Market Overview
23.2. North America Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Neurostimulators Market

24.1. USA Implantable Neurostimulators Market Overview
24.2. USA Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Neurostimulators Market

25.1. Canada Implantable Neurostimulators Market Overview
25.2. Canada Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Neurostimulators Market

26.1. South America Implantable Neurostimulators Market Overview
26.2. South America Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Neurostimulators Market

27.1. Brazil Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Neurostimulators Market

28.1. Middle East Implantable Neurostimulators Market Overview
28.2. Middle East Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Neurostimulators Market

29.1. Africa Implantable Neurostimulators Market Overview
29.2. Africa Implantable Neurostimulators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Implantable Neurostimulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Implantable Neurostimulators Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Neurostimulators Market Competitive Landscape And Company Profiles

30.1. Implantable Neurostimulators Market Competitive Landscape
30.2. Implantable Neurostimulators Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. LivaNova plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Inspire Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Neurostimulators Market Other Major And Innovative Companies

31.1. Nevro Corporation
31.2. Axonics Inc.
31.3. Cirtec Medical Systems LLC
31.4. SPR Therapeutics Inc.
31.5. BlueWind Medical Ltd.
31.6. NeuroPace Inc.
31.7. Bioness Inc.
31.8. ReShape Lifesciences Inc.
31.9. Synapse Biomedical Inc.
31.10. Autonomic Technologies Inc.
31.11. Comphya SA
31.12. Mainstay Medical Holdings plc
31.13. Sigenics Inc.
31.14. Nalu Medical Inc.
31.15. Aleva Neurotherapeutics SA

32. Global Implantable Neurostimulators Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Neurostimulators Market

34. Recent Developments In The Implantable Neurostimulators Market

35. Implantable Neurostimulators Market High Potential Countries, Segments and Strategies

35.1 Implantable Neurostimulators Market In 2029 - Countries Offering Most New Opportunities
35.2 Implantable Neurostimulators Market In 2029 - Segments Offering Most New Opportunities
35.3 Implantable Neurostimulators Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33496_Implantable_Neurostimulators_GMR_2025